GYRE THERAPEUTICS INC (GYRE) Stock Analyst Ratings
NASDAQ:GYRE - Nasdaq - US4037831033 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to GYRE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.4. This target is 172.36% above the current price.
GYRE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GYRE.
In the previous month the buy percentage consensus was at a similar level.
GYRE was analyzed by 7 analysts. More opinions would make the average more meaningful.